Advertisement

Ads Placeholder
Loading...

iX Biopharma Ltd.

42C.SI•SES
Healthcare
Drug Manufacturers - Specialty & Generic
S$0.20
S$-0.00(-1.50%)
Singapore Market opens in 55h 27m

iX Biopharma Ltd. (42C.SI) Stock Overview

Explore iX Biopharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap204.5M
P/E Ratio-17.12
EPS (TTM)$-0.01
ROE-4.51%
Fundamental Analysis

AI Price Forecasts

1 Month$0.25
3 Months$0.33
1 Year Target$1.06

42C.SI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of iX Biopharma Ltd. (42C.SI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.06.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.12 and a market capitalization of 204.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.50%
5-Day Change
-0.51%
1-Month Change
3.14%
3-Month Change
33.11%
6-Month Change
310.42%
Year-to-Date (YTD) Change
33.11%
1-Year Change
885.00%
3-Year Change
131.76%
5-Year Change
-13.31%
All-Time (Max) Change
-63.90%

Contact Information

https://www.ixbiopharma.com
65 6235 2270
No. 14-01 Great World City East Lobby, Singapore, NaN, 237994

Company Facts

350 Employees
IPO DateJul 22, 2015
CountrySG
Actively Trading

Frequently Asked Questions